Web Analytics

Investor Profile

Sofinnova Partners

Sofinnova Partners France - Paris, Ile-de-France
INVESTOR

1 Disclosed Funding Rounds $31,300,000
27 Participating Investments




Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a tea

Invested In

Company Date Round Raised
  Moon Surgical June, 30 ,2022 Series A $31,300,000
  Mediar Therapeutics March, 15 ,2023 Unknown $105,000,000
  deepc March, 31 ,2023 Series A $13,062,000
  BioCorteX March, 31 ,2023 Seed $5,000,000
  Kiro April, 03 ,2023 Series A $14,955,000
  Werewool May, 12 ,2023 Seed $3,700,000
  TISSIUM May, 23 ,2023 Series D $50,000,000
  BrightHeart June, 01 ,2023 Seed $2,151,000
  AAVantgarde Bio June, 07 ,2023 Series A $65,333,745
  Mozart Therapeutics, Inc June, 08 ,2023 Series A $25,000,000
  Gradient Denervation Technologies September, 08 ,2023 Series A $15,015,000
  Mironid® Limited September, 14 ,2023 Series A
  Sitryx September, 28 ,2023 Unknown $39,500,000
  Bon Vivant October, 13 ,2023 Seed $15,800,000
  Betteromics October, 27 ,2023 Series A $20,000,000
  l'école AI October, 27 ,2023 Seed $3,000,000
  T-Therapeutics Ltd November, 16 ,2023 Series A $59,707,000
  Freya Biosciences December, 13 ,2023 Series A $38,000,000
  DISCO Pharmaceuticals GmbH January, 17 ,2024 Seed $21,727,000
  Bioptimus February, 21 ,2024 Seed $35,000,000
  Mission Therapeutics March, 15 ,2024 Unknown $32,101,650
  Cure51 March, 20 ,2024 Seed $16,260,975
  May Health May, 14 ,2024 Series B $25,000,000
  Myricx Bio July, 09 ,2024 Series A $115,246,800
  Micropep Technologies July, 26 ,2024 Series B $29,000,000
  F2G September, 13 ,2024 Unknown $100,000,000
  Genespire September, 26 ,2024 Series B $51,969,485